Pharmaceuticals, Biotechnology and Life Sciences
BURLINGTON, Mass.–(BUSINESS WIRE)–$SCPH #FUROSCIX–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential…
EMERYVILLE, Calif.–(BUSINESS WIRE)–Eureka Therapeutics, Inc., a clinical stage biotechnology company developing novel T cell therapies to treat solid tumors, today…
Presenting Ten Research Studies using the Cancer Transcriptome Atlas to Discover Novel Biomarkers and First Data from Forthcoming Whole Transcriptome…
MENLO PARK, Calif.–(BUSINESS WIRE)–Bluestar Adisseo Company (Adisseo), a world leader in feed additives for animal nutrition, and the world’s leading…
SAN DIEGO–(BUSINESS WIRE)–#bio—Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today…
GSK to obtain access to two Immatics TCR-T programs, further advancing their commitment to the field of cell therapies Immatics…
Results from Phase 2 study published in the New England Journal of Medicine. Nemolizumab met the primary endpoint of a…
LONDON & BOSTON & TOKYO–(BUSINESS WIRE)–#biopharma–Stock market gains and dealmaking activity in Q4 clinched the biopharma sector’s strong performance in…
TORONTO–(BUSINESS WIRE)–#FSDDF—FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) (“FSD Pharma” or the “Company”) today announced the sale of…
– Liposomal Cyclosporine A for Inhalation (L‑CsA‑i) is advancing in clinical studies for the treatment for bronchiolitis obliterans syndrome (BOS)…